Two medical technology companies announce collaboration to improve efficiency and quality of RFID syringes

Recently, BD and ten23 health announced a collaboration to develop a tracking solution for prefilled syringes (PFS) based on RFID technology to improve the management efficiency and safety of medical devices. RFID technology can achieve real-time tracking and monitoring of prefilled syringes, thereby ensuring their correct use and timely replacement during medical treatment, reducing medical errors and patient risks.

The solution is branded as BD iDFill™ and is designed to improve efficiency and traceability in the production process and product distribution process. This will benefit ten23 health and its customers by ensuring higher traceability throughout the manufacturing process and supply chain, and realizing applications such as automated reconciliation, confusion prevention and investigation management.

RFID technology has been widely used in the management and tracking of medical devices. By installing RFID electronic tags on medical devices, real-time monitoring and tracking of devices can be achieved, improving the efficiency and safety of medical device use. The solution will be able to track and monitor information such as the location, usage and remaining validity period of prefilled syringes in real time.

The solution can automatically record the use of equipment and remind medical staff to replace or replenish equipment in a timely manner, thereby avoiding problems such as equipment shortages or expiration. More importantly, the RFID solution can also help medical staff ensure that medical devices such as prefilled syringes are used at the right time and place.

BD (Becton, Dickinson and Company) is a medical technology company founded in 1897 and headquartered in Franklin Lakes, New Jersey, USA. They are mainly focused on the research, development, production and sales of medical devices, medical systems and reagents. Its business covers medical consumables, laboratory instruments, antibodies, reagents, diagnostics and other fields. It has about 29,000 employees worldwide who are committed to promoting the advancement and innovation of medical technology.

And ten23 health is a Swiss company focusing on medical technology innovation. One of their main businesses is to develop innovative medical technologies, especially in the field of injection therapy. Its products may include a variety of advanced syringes, drug delivery systems, etc., designed to improve patient treatment and comfort. In addition, ten23 health also focuses on the manufacturing and filling of biologics, which are sensitive to temperature and manufacturing pressure and are usually used for applications such as intraocular or subcutaneous injections.